FORMULA GROWTH LTD - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 62 filers reported holding OBALON THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FORMULA GROWTH LTD ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$374,000
-48.1%
108,9980.0%0.04%
-53.7%
Q4 2017$720,000
-30.7%
108,9980.0%0.10%
-41.7%
Q3 2017$1,039,000
-3.8%
108,9980.0%0.16%
-12.4%
Q2 2017$1,080,000
-7.3%
108,9980.0%0.19%
-23.5%
Q1 2017$1,165,000
+75.5%
108,998
+45.3%
0.24%
+57.8%
Q4 2016$664,00074,9980.15%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 2,453,338$23,380,0006.09%
Tamarack Advisers, LP 547,536$5,218,0003.20%
LEVEL FOUR ADVISORY SERVICES, LLC 330,427$3,149,0000.28%
Moisand Fitzgerald Tamayo, LLC 6,875$281,0000.17%
FORMULA GROWTH LTD 108,998$1,039,0000.16%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 351,284$3,348,0000.15%
KORNITZER CAPITAL MANAGEMENT INC /KS 423,390$4,035,0000.07%
TIVERTON ASSET MANAGEMENT LLC 123,800$1,179,0000.07%
Granite Investment Partners, LLC 108,758$1,036,0000.06%
Bellevue Group AG 48,000$457,0000.05%
View complete list of OBALON THERAPEUTICS INC shareholders